Sanofi (LON:0O59)

London flag London · Delayed Price · Currency is GBP · Price in EUR
91.62
+2.00 (2.23%)
At close: Apr 14, 2025
5.57%
Market Cap 95.24B
Revenue (ttm) 36.62B
Net Income (ttm) 4.60B
Shares Out n/a
EPS (ttm) 3.67
PE Ratio 20.71
Forward PE n/a
Dividend 3.23 (3.53%)
Ex-Dividend Date May 12, 2025
Volume 2,267,371
Average Volume 840,773
Open 91.42
Previous Close 89.62
Day's Range 90.88 - 91.97
52-Week Range 70.18 - 87.94
Beta 0.48
RSI 32.59
Earnings Date Apr 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 82,878
Stock Exchange London Stock Exchange
Ticker Symbol 0O59
Full Company Profile

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.